跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 45 条关于
“Gpx4”
全部
45
临床试验
12
药物
11
机构
0
资讯
22
去年
Rubedo Life Sciences Initiates First-Ever GPX4 Modulator Clinical Trial for Psoriasis and Skin Aging
5个月前
Rubedo Life Sciences Reports Positive Phase 1 Results for First-in-Class GPX4 Modulator RLS-1496 in Dermatological Conditions
去年
Ferroptosis Emerges as Novel Therapeutic Target in Cancer Treatment and Immunotherapy
4个月前
Exploiting a New Weakness in 'Zombie-Like' Senescent Cells to Treat Cancer and Age-Associated Diseases
去年
Ferroptosis-Inducing Drug Auranofin Shows Promise in Combination with Chemotherapy for Resistant Neuroblastoma
去年
PRDX6 Enzyme Inhibition Shows Promise in Neuroblastoma Treatment
2个月前
Genetic Markers SPOP and CHD1 Identified as Key Determinants of Ferroptosis Sensitivity in Advanced Prostate Cancer
5个月前
PRMT5 Inhibition Sensitizes B-Cell Lymphoma to Ferroptosis via ATF5-SLC7A11 Axis
10个月前
Rubedo Life Sciences Partners with SVAX to Advance Anti-Aging Drug RLS-1496 in Middle East Phase 2 Trials
3个月前
NRF2's Dual Role in Ferroptosis: A Context-Dependent Switch for Cancer Therapy
第 1 页,共 3 页
上一页
下一页